AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 178 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $400,653 | +4.2% | 16,188 | +19.2% | 0.00% | – |
Q2 2023 | $384,557 | +17.0% | 13,579 | -5.1% | 0.00% | – |
Q1 2023 | $328,746 | -1.7% | 14,312 | +20.1% | 0.00% | – |
Q4 2022 | $334,489 | -51.3% | 11,912 | -51.0% | 0.00% | -100.0% |
Q3 2022 | $687,000 | -27.8% | 24,291 | -43.4% | 0.00% | 0.0% |
Q2 2022 | $951,000 | -54.4% | 42,915 | -40.1% | 0.00% | 0.0% |
Q1 2022 | $2,087,000 | -37.0% | 71,693 | -28.9% | 0.00% | -50.0% |
Q4 2021 | $3,314,000 | -35.8% | 100,819 | -9.9% | 0.00% | -33.3% |
Q3 2021 | $5,163,000 | -19.6% | 111,873 | -4.0% | 0.00% | -25.0% |
Q2 2021 | $6,423,000 | +17.1% | 116,543 | +9.7% | 0.00% | 0.0% |
Q1 2021 | $5,486,000 | +37.6% | 106,223 | +15.5% | 0.00% | +33.3% |
Q4 2020 | $3,986,000 | +683.1% | 92,001 | +533.0% | 0.00% | – |
Q3 2020 | $509,000 | -53.1% | 14,535 | -28.5% | 0.00% | -100.0% |
Q2 2020 | $1,086,000 | +103.8% | 20,320 | +35.3% | 0.00% | 0.0% |
Q1 2020 | $533,000 | -17.1% | 15,018 | +11.6% | 0.00% | 0.0% |
Q4 2019 | $643,000 | +119.5% | 13,453 | +48.5% | 0.00% | – |
Q3 2019 | $293,000 | -56.3% | 9,057 | -32.7% | 0.00% | -100.0% |
Q2 2019 | $671,000 | -33.3% | 13,452 | -9.9% | 0.00% | 0.0% |
Q1 2019 | $1,006,000 | +58.9% | 14,925 | +8.7% | 0.00% | 0.0% |
Q4 2018 | $633,000 | -48.3% | 13,731 | -13.5% | 0.00% | 0.0% |
Q3 2018 | $1,225,000 | -4.7% | 15,881 | +4.2% | 0.00% | 0.0% |
Q2 2018 | $1,285,000 | +5.5% | 15,248 | +2.4% | 0.00% | 0.0% |
Q1 2018 | $1,218,000 | +59.4% | 14,895 | +11.5% | 0.00% | 0.0% |
Q4 2017 | $764,000 | +101.6% | 13,362 | +135.1% | 0.00% | – |
Q3 2017 | $379,000 | +4.1% | 5,683 | -19.8% | 0.00% | – |
Q2 2017 | $364,000 | +17.8% | 7,083 | +33.8% | 0.00% | – |
Q1 2017 | $309,000 | +30.9% | 5,294 | -6.2% | 0.00% | – |
Q4 2016 | $236,000 | -25.1% | 5,645 | -5.2% | 0.00% | – |
Q3 2016 | $315,000 | +26.0% | 5,956 | 0.0% | 0.00% | – |
Q2 2016 | $250,000 | -16.9% | 5,956 | +28.5% | 0.00% | – |
Q4 2015 | $301,000 | -8.8% | 4,635 | -0.7% | 0.00% | -100.0% |
Q3 2015 | $330,000 | +28.9% | 4,668 | +72.1% | 0.00% | – |
Q1 2015 | $256,000 | +4.9% | 2,713 | +24.3% | 0.00% | – |
Q4 2014 | $244,000 | -11.9% | 2,182 | -51.8% | 0.00% | – |
Q3 2014 | $277,000 | -82.7% | 4,523 | -89.0% | 0.00% | -100.0% |
Q1 2014 | $1,605,000 | +65.1% | 41,000 | +1.0% | 0.00% | +50.0% |
Q4 2013 | $972,000 | -13.1% | 40,600 | +1.5% | 0.00% | 0.0% |
Q3 2013 | $1,118,000 | – | 40,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |